Is microincisional surgery really the best option?

Article

The trend for microincisional procedures is escalating. Dr Boris Malyugin compares SICS and C-MICS.

Key Points

Because a MICS incision is smaller than the incision created by the conventional coaxial technique, one might expect improved outcomes, resulting in improved visual acuity. Previously published studies have established that the MICS technique is truly astigmatically neutral, making it ideal for refractive lens exchange; the technique is also associated with a decreased likelihood of postoperative wound leakage when compared with a larger incision procedure, thereby also reducing the risk of endophthalmitis.

B-MICS and C-MICS

That is why, nowadays, most surgeons prefer the coaxial surgical technique. My personal preference is a C-MICS procedure performed completely through an unenlarged 1.8 mm incision with the Stellaris system (Bausch & Lomb).

To evacuate the lens material through the smaller bore needle used in this technique, it is necessary to fragment the lens into particles of smaller diameter than is required by the standard diameter ultrasound (US) needle. Theoretically, with the larger diameter phaco needle, one could expect that, to emulsify the lens nucleus, a lower amount of US energy would be necessary.

Comparing C-MICS with SICS

Although there have previously been a number of studies assessing the outcomes of MICS, no studies have, to the best of my knowledge, compared the postoperative outcomes of 1.8 mm C-MICS with the outcomes of 2.8 mm SICS (small incision cataract surgery) when performed with the latest generation of phaco machines.

I conducted a study to assess if the differences in both the incision size and the US needle diameter - when using the same system and the same settings - influence either the utilization of the US energy and irrigating fluid or the clinical outcomes of cataract surgery.

Both groups underwent phacoemulsification using the same surgical settings:

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.